Model
Edge
Acura Pharmaceuticals, Inc
ACUR
Filing Type
8-K
Filing Date
9/3/2025
Updated
9/4/25, 6:22 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant